date,title,source
Oct-25-18,Is argenx SEs (EBR:ARGX) Liquidity Good Enough?,Simply Wall St.
Oct-25-18,argenx reports third quarter 2018 financial results and provides business update,GlobeNewswire
Nov-01-18,argenx announces new cusatuzumab (ARGX-110) AML data in abstracts published in connection with 60th American Society of Hematology Annual Meeting and Exposition,GlobeNewswire
Dec-03-18,"Dutch firm argenx, J&J affiliate to collaborate on cancer therapy",Reuters
Dec-03-18,argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia,GlobeNewswire
Dec-03-18,"argenx enters exclusive global collaboration and license agreement with Cilag GmbH International, an affiliate of Janssen, for cusatuzumab (ARGX-110)",GlobeNewswire
Dec-26-18,6 Valuable Pipeline Drugs With Upcoming Catalysts,Benzinga
Jan-22-19,Who Has Been Selling argenx SE (EBR:ARGX) Shares?,Simply Wall St.
Jan-23-19,Today's Research Reports on Trending Tickers: Editas Medicine and argenx,ACCESSWIRE
